KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Equity Average (2016 - 2025)

Historic Equity Average for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $7.3 billion.

  • Quest Diagnostics' Equity Average rose 787.58% to $7.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 billion, marking a year-over-year increase of 787.58%. This contributed to the annual value of $6.6 billion for FY2024, which is 719.52% up from last year.
  • As of Q3 2025, Quest Diagnostics' Equity Average stood at $7.3 billion, which was up 787.58% from $7.1 billion recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' Equity Average peaked at $7.3 billion during Q3 2025, and registered a low of $6.0 billion during Q1 2023.
  • In the last 5 years, Quest Diagnostics' Equity Average had a median value of $6.4 billion in 2022 and averaged $6.5 billion.
  • Per our database at Business Quant, Quest Diagnostics' Equity Average soared by 1939.42% in 2021 and then plummeted by 682.28% in 2023.
  • Quarter analysis of 5 years shows Quest Diagnostics' Equity Average stood at $6.5 billion in 2021, then decreased by 5.52% to $6.1 billion in 2022, then increased by 4.94% to $6.4 billion in 2023, then increased by 6.63% to $6.8 billion in 2024, then grew by 6.64% to $7.3 billion in 2025.
  • Its last three reported values are $7.3 billion in Q3 2025, $7.1 billion for Q2 2025, and $6.9 billion during Q1 2025.